<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hassan Bakos, Author at Memphasys Reproductive Biotechnology</title>
	<atom:link href="https://www.memphasys-felix-japan.com/author/hassan-bakos/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.memphasys-felix-japan.com/author/hassan-bakos/</link>
	<description>Better technology, more life</description>
	<lastBuildDate>Wed, 07 Aug 2024 04:22:19 +0000</lastBuildDate>
	<language>en-AU</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.6.2</generator>

<image>
	<url>https://www.memphasys-felix-japan.com/wp-content/uploads/2022/06/cropped-Memphasys-Icon-32x32.png</url>
	<title>Hassan Bakos, Author at Memphasys Reproductive Biotechnology</title>
	<link>https://www.memphasys-felix-japan.com/author/hassan-bakos/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>メンファシス、精子分離装置の商業承認を加速</title>
		<link>https://www.memphasys-felix-japan.com/memphasys-accelerates-commercial-approval-for-sperm-separation-device/</link>
					<comments>https://www.memphasys-felix-japan.com/memphasys-accelerates-commercial-approval-for-sperm-separation-device/#respond</comments>
		
		<dc:creator><![CDATA[Hassan Bakos]]></dc:creator>
		<pubDate>Tue, 16 Jan 2024 02:05:55 +0000</pubDate>
				<category><![CDATA[News and Articles]]></category>
		<category><![CDATA[FelixTM IVF Sperm]]></category>
		<category><![CDATA[Reproductive Biotechnology]]></category>
		<guid isPermaLink="false">https://www.memphasys.com/?p=105098</guid>

					<description><![CDATA[<p>Memphasys recently signed an exclusive distribution agreement with Vitrolife Japan KK, a subsidiary of the Vitrolife Group, to sell and distribute the FelixTM IVF sperm separation system in Japan for five years. </p>
<p>The post <a href="https://www.memphasys-felix-japan.com/memphasys-accelerates-commercial-approval-for-sperm-separation-device/">&lt;span data-no-translation&gt;メンファシス、精子分離装置の商業承認を加速&lt;/span&gt;</a> appeared first on <a href="https://www.memphasys-felix-japan.com">Memphasys Reproductive Biotechnology</a>.</p>
]]></description>
										<content:encoded><![CDATA[<span data-no-translation><p>Despite innovative technology, Memphasys (ASX:MEM) has been swimming against the tide in recent times. But with the company poised to bank $4.23 million in a capital raising and having signed expanded distribution agreements, wary investors can expect better times as the company shifts from a research and development focus to commercialisation.</p>
<p>Memphasys acting CEO Dr David Ali acknowledges the ASX-listed company needs to expedite the registration study for its flagship assisted sperm-separation system, Felix. in 2024.</p>
<p>“The company has been driven largely by R&amp;D and it’s time to flip that to commercialisation. Whilst we have an unparalleled innovation hub, we will be seeking to build on commercial planning. We will adopt a view of innovative transformative research with a clear path to commercial outcomes,” he says.</p>
<p><a href="https://www.sharecafe.com.au/2024/01/10/memphasys-accelerates-commercial-approval-for-sperm-separation-device/">READ THE FULL ARTICLE ON SHARECAFE HERE</a></p></span><p>The post <a href="https://www.memphasys-felix-japan.com/memphasys-accelerates-commercial-approval-for-sperm-separation-device/">&lt;span data-no-translation&gt;メンファシス、精子分離装置の商業承認を加速&lt;/span&gt;</a> appeared first on <a href="https://www.memphasys-felix-japan.com">Memphasys Reproductive Biotechnology</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.memphasys-felix-japan.com/memphasys-accelerates-commercial-approval-for-sperm-separation-device/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Meet Hassan Bakos: Driving Operational Excellence at Memphasys</title>
		<link>https://www.memphasys-felix-japan.com/meet-hassan-bakos/</link>
					<comments>https://www.memphasys-felix-japan.com/meet-hassan-bakos/#respond</comments>
		
		<dc:creator><![CDATA[Hassan Bakos]]></dc:creator>
		<pubDate>Sat, 17 Jun 2023 06:53:50 +0000</pubDate>
				<category><![CDATA[News and Articles]]></category>
		<guid isPermaLink="false">https://localhost/lock-stock/memphasys//?p=104807</guid>

					<description><![CDATA[<p>I’m now a month into my new role at Memphasys, where I am working closely with a talented team and a product that I am very familiar with. Over the past three years in particular, I have enjoyed a strong and trusted relationship with the Memphasys team, focusing specifically on the development of the Felix&#8482; System.</p>
<p>The post <a href="https://www.memphasys-felix-japan.com/meet-hassan-bakos/">&lt;span data-no-translation&gt;Meet Hassan Bakos: Driving Operational Excellence at Memphasys&lt;/span&gt;</a> appeared first on <a href="https://www.memphasys-felix-japan.com">Memphasys Reproductive Biotechnology</a>.</p>
]]></description>
										<content:encoded><![CDATA[<span data-no-translation><div data-parent="true" class="vc_row row-container" id="row-unique-0"><div class="row penta-top-padding penta-bottom-padding single-h-padding limit-width row-parent"><div class="wpb_row row-inner"><div class="wpb_column pos-top pos-center align_left column_parent col-lg-12 single-internal-gutter"><div class="uncol style-light"  ><div class="uncoltable"><div class="uncell" ><div class="uncont no-block-padding col-custom-width" style="max-width:996px;"><div class="uncode_text_column" ><p>I’m now a month into my new role at Memphasys, where I am working closely with a talented team and a product that I am very familiar with. Over the past three years in particular, I have enjoyed a strong and trusted relationship with the Memphasys team, focusing specifically on the development of the Felix&trade; System.</p>
<div></div>
<p>Making the move to Memphasys feels like a very natural career progression, following 17 years in the ART industry. It all started during my time at the University of Adelaide, where my interest in fertility began. Whilst at the time, the emphasis was on female infertility, I decided to focus on male obesity and infertility.</p>
<div></div>
<p>During my undergraduate years, I had the privilege of learning from and being inspired by several influential figures. However, Professor John Aitken, (Laureate Professor of Biological Sciences) played a pivotal role as a constant source of inspiration.</p>
<div></div>
<p>With my transition to Memphasys, I feel incredibly comfortable because I have an extensive understanding of the Felix&trade; System. This technology is truly unique and unrivalled in the market. Given my strong belief in its capabilities, I am genuinely thrilled about assisting Memphasys in their journey to the next stage of their business.</p>
<div></div>
<p>Although my role is primarily in operations, it also allows me to contribute to the scientific front, leveraging the skill set I developed over the years.</p>
<div></div>
<p>Recently as a key opinion leader with Vitrolife, I had the privilege of collaborating with Professor John Aitken on a product review, and I took great pride in sharing our findings at the FSANZ conference on the Gold Coast.</p>
<p>
</div><span class="btn-container" ><a href="https://www.memphasys.com/contact-us/" class="custom-link btn border-width-0 btn-accent btn-icon-left" target="_blank">Contact us to find out more about Memphasys</a></span></div></div></div></div></div><script id="script-row-unique-0" data-row="script-row-unique-0" type="text/javascript" class="vc_controls">UNCODE.initRow(document.getElementById("row-unique-0"));</script></div></div></div></span><p>The post <a href="https://www.memphasys-felix-japan.com/meet-hassan-bakos/">&lt;span data-no-translation&gt;Meet Hassan Bakos: Driving Operational Excellence at Memphasys&lt;/span&gt;</a> appeared first on <a href="https://www.memphasys-felix-japan.com">Memphasys Reproductive Biotechnology</a>.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://www.memphasys-felix-japan.com/meet-hassan-bakos/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
